These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8824964)

  • 1. Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression.
    Pulvirenti JJ; Kerns E; Benson C; Lisowski J; Demarais P; Weinstein RA
    Clin Infect Dis; 1996 Jan; 22(1):40-5. PubMed ID: 8824964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients.
    Nahass RG; Weinstein MP; Bartels J; Gocke DJ
    J Infect Dis; 1990 Oct; 162(4):967-70. PubMed ID: 2401795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users.
    Ribera E; Miró JM; Cortés E; Cruceta A; Merce J; Marco F; Planes A; Paré JC; Moreno A; Ocaña I; Gatell JM; Pahissa A
    Arch Intern Med; 1998 Oct; 158(18):2043-50. PubMed ID: 9778205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
    JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users.
    Caiaffa WT; Vlahov D; Graham NM; Astemborski J; Solomon L; Nelson KE; Muñoz A
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1493-8. PubMed ID: 7952605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
    Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus infection and infective endocarditis among injecting drug users.
    Manoff SB; Vlahov D; Herskowitz A; Solomon L; Muñoz A; Cohn S; Willoughby SB; Nelson KE
    Epidemiology; 1996 Nov; 7(6):566-70. PubMed ID: 8899380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients.
    De Rosa FG; Cicalini S; Canta F; Audagnotto S; Cecchi E; Di Perri G
    Infection; 2007 Jun; 35(3):154-60. PubMed ID: 17565456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of CD4+ lymphocyte count among HIV-seropositive and HIV-seronegative pregnant women in Dar es Salaam, Tanzania.
    Kapiga SH; Mwakagile D; Spiegelman D; Msamanga GI; Hunter D; Fawzi WW
    East Afr Med J; 2000 Apr; 77(4):206-11. PubMed ID: 12858905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group.
    Hirschtick RE; Glassroth J; Jordan MC; Wilcosky TC; Wallace JM; Kvale PA; Markowitz N; Rosen MJ; Mangura BT; Hopewell PC
    N Engl J Med; 1995 Sep; 333(13):845-51. PubMed ID: 7651475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin E levels in relationship to HIV-1 disease, route of infection, and vitamin E status.
    Miguez-Burbano MJ; Shor-Posner G; Fletcher MA; Lu Y; Moreno JN; Carcamo C; Page B; Quesada J; Sauberlich H; Baum MK
    Allergy; 1995 Feb; 50(2):157-61. PubMed ID: 7604939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of the leading pathogens in human immunodeficiency virus-infected adults with community-onset bacteremia in the emergency department: The importance of transmission routes.
    Lee CC; Chou YJ; Lin JN; Chu FY; Tang HJ; Lai CH; Lin HH; Hung CC; Ko WC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):392-400. PubMed ID: 28082067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users.
    Grbic JT; Mitchell-Lewis DA; Fine JB; Phelan JA; Bucklan RS; Zambon JJ; Lamster IB
    J Periodontol; 1995 Jan; 66(1):30-7. PubMed ID: 7891247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infective endocarditis in intravenous drug users: does HIV status alter the presenting temperature and white blood cell count?
    Robinson DJ; Lazo MC; Davis T; Kufera JA
    J Emerg Med; 2000 Jul; 19(1):5-11. PubMed ID: 10863111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature.
    Losa JE; Miro JM; Del Rio A; Moreno-Camacho A; Garcia F; Claramonte X; Marco F; Mestres CA; Azqueta M; Gatell JM;
    Clin Microbiol Infect; 2003 Jan; 9(1):45-54. PubMed ID: 12691542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths.
    Douglas SD; Durako S; Sullivan KE; Camarca M; Moscicki AB; Wilson CM
    Clin Diagn Lab Immunol; 2003 May; 10(3):399-404. PubMed ID: 12738638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal Parasitic Infections and Immunological Status of HIV/AIDS Coinfected Individuals in Nigeria.
    Udeh EO; Obiezue RNN; Okafor FC; Ikele CB; Okoye IC; Otuu CA
    Ann Glob Health; 2019 Jul; 85(1):. PubMed ID: 31276332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of infective endocarditis over ten years in Taiwan.
    Hung HC; Chen SC; Chan KC; Tsui TL; Tsao SM; Leel YT; Wu DJ
    J Heart Valve Dis; 2013 Mar; 22(2):248-56. PubMed ID: 23798216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort.
    Gebo KA; Burkey MD; Lucas GM; Moore RD; Wilson LE
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):426-32. PubMed ID: 17099314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.